Clinical Trial Update: Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Modified Dakin's Solution to reduce radiation-induced dermatitis in head and neck cancer patients undergoing radiotherapy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Radiation-induced Dermatitis

Drugs mentioned

• Modified Dakin's Solution

Snippet

Sponsor: Stanford University | Conditions: Head and Neck Carcinoma, Radiation-Induced Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2019-09-17